Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
| Revenue (Most Recent Fiscal Year) | $693.40M |
| Net Income (Most Recent Fiscal Year) | $-705.81M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 11.28 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 24.56 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -22.12% |
| Net Margin (Trailing 12 Months) | -18.45% |
| Return on Equity (Trailing 12 Months) | -73.21% |
| Return on Assets (Trailing 12 Months) | -13.78% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.28 |
| Quick Ratio (Most Recent Fiscal Quarter) | 3.12 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 2.45 |
| Inventory Turnover (Trailing 12 Months) | 8.84 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.92 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.31 |
| Earnings per Share (Most Recent Fiscal Year) | $-6.04 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.19 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Common Shares Outstanding | 173.73M |
| Free Float | 128.09M |
| Market Capitalization | $12.47B |
| Average Volume (Last 20 Days) | 6.76M |
| Beta (Past 60 Months) | 4.86 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 26.27% |
| Percentage Held By Institutions (Latest 13F Reports) | 24.22% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |